Shengtian Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shengtian Zhao has a total of 232 co-authors. Here are the top co-authors by number of shared publications:
Feng Kong
Department of Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China; Shandong Provincial Engineering Laboratory of Urologic Tissue Reconstruction, Jinan, China
18 shared publicationsKailin Li
Central Research Laboratory, Institute of Medical Science, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
14 shared publicationsChao Sun
Institute of Medical Sciences, The Second Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University
12 shared publicationsDenglu Zhang
Department of Urology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
11 shared publicationsBaozhen Fan
Shandong Engineering Research Center of Molecular Medicine for Renal Diseases, Yantai, Shandong, CHINA; Laboratory of Tight Junction, Binzhou Medical University, Yantai, Shandong, CHINA; Department of Urology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, CHINA
9 shared publications- Dawei Xu
Department of Medicine, Division of Hematology, Bioclinicum and Center for Molecular Medicine, Karolinska Institute and Karolinska University Hospital Solna, Stockholm, Sweden
9 shared publications
Latest Publications
- Open Access
- 29 April 2026
- Published by Taylor & Francis in Renal Failure
- Vol. 48 (1) , 2628409
Functional urine production and glomerular maturation from embryonic metanephros transplanted at the renal hilum in rats
End-stage renal disease remains a major global health burden, and novel regenerative strategies are urgently needed. Embryonic metanephros transplantation has emerged as a promising approach, but the optimal site for engraftment and functional maturation is unclear. In this study, embryonic day 15.5 metanephroi with attached bladder (MNB) were transplanted into adult rats at three sites: the renal hilum, renal subcapsular space, and omentum. After four weeks, grafts were assessed for survival, vascularization, nephron differentiation, and functional urine production. Compared with subcapsular and omental sites, hilum transplantation yielded markedly improved graft revasculari-zation and glomerular maturation, as demonstrated by enhanced expression of podocyte and tubular markers, as well as reduced interstitial fibrosis. Importantly, transplanted kidneys at the hilum produced urine containing creatinine and urea nitrogen, confirming functional integration with the host. These findings highlight the renal hilum as a superior anatomical niche for embryonic kidney transplantation, providing enhanced vascular supply and a microenvironment conducive to functional maturation. This work provides foundational evidence for the translational potential of renal hilum implantation as a strategy to generate functional renal tissue in vivo.
- 29 April 2026
- Published by Taylor & Francis in Renal Failure
- Vol. 48 (1) , 2628409
Open AccessFunctional urine production and glomerular maturation from embryonic metanephros transplanted at the renal hilum in rats
End-stage renal disease remains a major global health burden, and novel regenerative strategies are urgently needed. Embryonic metanephros transplantation has emerged as a promising approach, but the optimal site for engraftment and functional maturation is unclear. In this study, embryonic day 15.5 metanephroi with attached bladder (MNB) were transplanted into adult rats at three sites: the renal hilum, renal subcapsular space, and omentum. After four weeks, grafts were assessed for survival, vascularization, nephron differentiation, and functional urine production. Compared with subcapsular and omental sites, hilum transplantation yielded markedly improved graft revasculari-zation and glomerular maturation, as demonstrated by enhanced expression of podocyte and tubular markers, as well as reduced interstitial fibrosis. Importantly, transplanted kidneys at the hilum produced urine containing creatinine and urea nitrogen, confirming functional integration with the host. These findings highlight the renal hilum as a superior anatomical niche for embryonic kidney transplantation, providing enhanced vascular supply and a microenvironment conducive to functional maturation. This work provides foundational evidence for the translational potential of renal hilum implantation as a strategy to generate functional renal tissue in vivo.
- Open Access
- 6 April 2026
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (4) , 102720
Patient-derived kidney organoids recapitulate ADPKD and facilitate the identification of Rho pathway inhibitors as candidate therapeutics
- 6 April 2026
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (4) , 102720
Open AccessPatient-derived kidney organoids recapitulate ADPKD and facilitate the identification of Rho pathway inhibitors as candidate therapeutics
- Open Access
- 13 January 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111163
CLDN5 as a novel modulator of podocyte adhesion to extracellular matrix via β1-integrin binding
- 13 January 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111163
Open AccessCLDN5 as a novel modulator of podocyte adhesion to extracellular matrix via β1-integrin binding
- Open Access
- 18 August 2025
- Published by Elsevier in Pharmacological Research
- Vol. 219, 107915
Precision targeting of androgen receptor–ferroptosis crosstalk in prostate cancer: From mechanisms to therapeutic strategies
- 18 August 2025
- Published by Elsevier in Pharmacological Research
- Vol. 219, 107915
Open AccessPrecision targeting of androgen receptor–ferroptosis crosstalk in prostate cancer: From mechanisms to therapeutic strategies
- Open Access
- 14 August 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-14
The ETS transcription factor GABPA inhibits bladder cancer aggressiveness by repressing extracellular matrix deposition and mechanotransduction signaling
The ETS transcription factor GABPA exhibits an oncogenic effect by activating telomerase in many cancers; however, some studies imply its tumor suppressive activities. It is thus important to define its different roles in oncogenesis. By examining GABPA-transgenic mice, we unexpectedly observed that Collagen I and III (Col I and III) contents were significantly reduced in murine dermis, which was accompanied by downregulation of prolyl 4-hydroxylase (P4HA2), an enzyme catalyzing collagen folding and fiber stabilization. In bladder cancer (BC) cells, GABPA similarly inhibited Col I and III formation, whereas Col levels increased upon GABPA depletion, revealing its modulation of extracellular matrix (ECM) deposition and stiffness. Mechanistically, GABPA induced miR-30e expression by stimulating DICER1 transcription, and higher levels of miR-30e consequently targeted P4HA2 for its downregulation. Consistently, P4HA2 overexpression promoted Col formation, cell proliferation, and invasion, while its depletion or the specific P4HA2 inhibitor exerted opposite effects. In tumors derived from GABPA-overexpressed BC cells, atomic force microscope assessment showed that ECM rigidity was significantly reduced, coupled with diminished metastasis in xenografted mice, while P4HA2 overexpression led to stiffer ECM and increased metastasis, counteracting the GABPA effect. Moreover, GABPA knockdown or P4HA2 overexpression promoted YAP1 expression and its nuclear translocation, activating mechanotransduction signaling, through which accelerated proliferation and epithelial-mesenchymal transition occurred. Consistently, high miR-30e and P4HA2 expression were associated with favorable and unfavorable outcomes in BC patients, respectively. Collectively, GABPA inhibits P4HA2 expression and Col formation through the DICER1-miR30e axis, thereby repressing ECM deposition/stiffness and blocking mechanotransduction signaling, which consequently restrains BC aggressiveness. These findings unravel a novel role for GABPA in BC pathogenesis and have biological and therapeutic implications.
- 14 August 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-14
Open AccessThe ETS transcription factor GABPA inhibits bladder cancer aggressiveness by repressing extracellular matrix deposition and mechanotransduction signaling
The ETS transcription factor GABPA exhibits an oncogenic effect by activating telomerase in many cancers; however, some studies imply its tumor suppressive activities. It is thus important to define its different roles in oncogenesis. By examining GABPA-transgenic mice, we unexpectedly observed that Collagen I and III (Col I and III) contents were significantly reduced in murine dermis, which was accompanied by downregulation of prolyl 4-hydroxylase (P4HA2), an enzyme catalyzing collagen folding and fiber stabilization. In bladder cancer (BC) cells, GABPA similarly inhibited Col I and III formation, whereas Col levels increased upon GABPA depletion, revealing its modulation of extracellular matrix (ECM) deposition and stiffness. Mechanistically, GABPA induced miR-30e expression by stimulating DICER1 transcription, and higher levels of miR-30e consequently targeted P4HA2 for its downregulation. Consistently, P4HA2 overexpression promoted Col formation, cell proliferation, and invasion, while its depletion or the specific P4HA2 inhibitor exerted opposite effects. In tumors derived from GABPA-overexpressed BC cells, atomic force microscope assessment showed that ECM rigidity was significantly reduced, coupled with diminished metastasis in xenografted mice, while P4HA2 overexpression led to stiffer ECM and increased metastasis, counteracting the GABPA effect. Moreover, GABPA knockdown or P4HA2 overexpression promoted YAP1 expression and its nuclear translocation, activating mechanotransduction signaling, through which accelerated proliferation and epithelial-mesenchymal transition occurred. Consistently, high miR-30e and P4HA2 expression were associated with favorable and unfavorable outcomes in BC patients, respectively. Collectively, GABPA inhibits P4HA2 expression and Col formation through the DICER1-miR30e axis, thereby repressing ECM deposition/stiffness and blocking mechanotransduction signaling, which consequently restrains BC aggressiveness. These findings unravel a novel role for GABPA in BC pathogenesis and have biological and therapeutic implications.
- Open Access
- 4 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-23
Adipocyte CLDN5 promotes thermogenesis and energy expenditure through regulation of IL10 expression
The claudin protein family plays key roles in maintaining normal structure and function of epithelial and endothelial tight junctions. While several prior studies have addressed the expression of claudin in adipocytes that do not form tight junctions, here we demonstrate that CLDN5 is selectively expressed in non-thermogenic adipocytes within adipose tissue. Ablation of CLDN5 in adipocyte impairs thermogenesis and energy expenditure. CLDN5 deficiency also significantly increases diet-induced fat mass in mice, accompanied with glucose intolerance and insulin resistance. Mechanistically, CLDN5 affects the subcellular localization of Y-box protein 3, which directly regulates IL10 expression via binding to its promoter and specific sites in 3′-untranslated region, thereby acts in a paracrine manner to signal through IL10R in neighbouring thermogenic adipocytes. These findings expand our understanding about location and function of the extra-tight junction claudin proteins and provide molecular insights into signaling mechanisms underlying adipose thermogenesis that could inform future therapy.
- 4 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-23
Open AccessAdipocyte CLDN5 promotes thermogenesis and energy expenditure through regulation of IL10 expression
The claudin protein family plays key roles in maintaining normal structure and function of epithelial and endothelial tight junctions. While several prior studies have addressed the expression of claudin in adipocytes that do not form tight junctions, here we demonstrate that CLDN5 is selectively expressed in non-thermogenic adipocytes within adipose tissue. Ablation of CLDN5 in adipocyte impairs thermogenesis and energy expenditure. CLDN5 deficiency also significantly increases diet-induced fat mass in mice, accompanied with glucose intolerance and insulin resistance. Mechanistically, CLDN5 affects the subcellular localization of Y-box protein 3, which directly regulates IL10 expression via binding to its promoter and specific sites in 3′-untranslated region, thereby acts in a paracrine manner to signal through IL10R in neighbouring thermogenic adipocytes. These findings expand our understanding about location and function of the extra-tight junction claudin proteins and provide molecular insights into signaling mechanisms underlying adipose thermogenesis that could inform future therapy.
- Open Access
- 13 March 2025
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 12, 1552085
A dual-reporter LDLR system integrating fluorescence and luminescence for understanding LDLR regulation and facilitating drug discovery
Introduction: The low-density lipoprotein receptor (LDLR) is integral to cholesterol metabolism and cardiovascular health. Enhancing LDLR expression is a promising strategy for treating hyperlipidemia and reducing the risk of atherosclerosis. However, current LDLR reporter systems have limitations in detecting both transcriptional and translational regulation. To address this, we developed a novel dual-reporter LDLR system incorporating Enhanced Green Fluorescent Protein (EGFP) and Gaussia luciferase (Gluc) to enable precise monitoring of LDLR expression and function.Methods: A CRISPR/Cas9-mediated knock-in strategy was used to integrate EGFP and Gluc upstream of the stop codon located in exon 18 of the LDLR gene in HEK293 cells. The dual-reporter system allows real-time visualization of LDLR expression via EGFP fluorescence and quantitative assessment through secreted Gluc activity. The system was validated using western blotting, immunofluorescence, and functional assays, including DiI-LDL uptake and drug response analyses with statins and PCSK9 inhibitors.Results: The established LDLR-EGFP-Gluc knock-in cell line faithfully recapitulates endogenous LDLR expression and function. EGFP fluorescence accurately reflects LDLR expression dynamics, while Gluc activity provides a highly sensitive and quantitative readout. Functional assays confirmed that LDLR expression responds appropriately to statins and PCSK9 inhibitors. Additionally, screening for transcriptional regulators identified FOXP3 and CREB as novel modulators of LDLR expression, with CREB-mediated regulation involving the sterol regulatory element-binding protein 2 (SREBP2) pathway.Discussion: This dual-reporter system enables complementary monitoring of LDLR dynamics, providing enhanced sensitivity, accuracy, and versatility for studying LDLR regulation and function, as well as facilitating drug discovery targeting hyperlipidemia and cardiovascular diseases.
- 13 March 2025
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 12, 1552085
Open AccessA dual-reporter LDLR system integrating fluorescence and luminescence for understanding LDLR regulation and facilitating drug discovery
Introduction: The low-density lipoprotein receptor (LDLR) is integral to cholesterol metabolism and cardiovascular health. Enhancing LDLR expression is a promising strategy for treating hyperlipidemia and reducing the risk of atherosclerosis. However, current LDLR reporter systems have limitations in detecting both transcriptional and translational regulation. To address this, we developed a novel dual-reporter LDLR system incorporating Enhanced Green Fluorescent Protein (EGFP) and Gaussia luciferase (Gluc) to enable precise monitoring of LDLR expression and function.Methods: A CRISPR/Cas9-mediated knock-in strategy was used to integrate EGFP and Gluc upstream of the stop codon located in exon 18 of the LDLR gene in HEK293 cells. The dual-reporter system allows real-time visualization of LDLR expression via EGFP fluorescence and quantitative assessment through secreted Gluc activity. The system was validated using western blotting, immunofluorescence, and functional assays, including DiI-LDL uptake and drug response analyses with statins and PCSK9 inhibitors.Results: The established LDLR-EGFP-Gluc knock-in cell line faithfully recapitulates endogenous LDLR expression and function. EGFP fluorescence accurately reflects LDLR expression dynamics, while Gluc activity provides a highly sensitive and quantitative readout. Functional assays confirmed that LDLR expression responds appropriately to statins and PCSK9 inhibitors. Additionally, screening for transcriptional regulators identified FOXP3 and CREB as novel modulators of LDLR expression, with CREB-mediated regulation involving the sterol regulatory element-binding protein 2 (SREBP2) pathway.Discussion: This dual-reporter system enables complementary monitoring of LDLR dynamics, providing enhanced sensitivity, accuracy, and versatility for studying LDLR regulation and function, as well as facilitating drug discovery targeting hyperlipidemia and cardiovascular diseases.
- Open Access
- 2 March 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2471011
The association between immune cells and acute kidney injury: insights from Mendelian randomization
Immune disorder is a prominent feature of acute kidney injury (AKI). However, the specific role of different immune cell phenotypes in the pathogenesis of AKI remains poorly understood. The aim of this study was to investigate the relevance of 731 immune phenotypes to AKI. We obtained data on 731 immune cell phenotypes from the GWAS Catalog and Open GWAS databases and undertook a series of quality control measures to identify exposure-related instrumental variables (IV). Data on acute renal failure (ARF) and rapid kidney function decline were obtained from the Finngen R11 and CKDGen databases as an outcome. Subsequently, we performed two-sample Mendelian randomization (MR) using inverse variance weights to explore the causal relationship between 731 immune cell characteristics and ARF and rapid kidney function declineas at the gene level. Sensitivity analyses, including leave-one-out and other MR analysis models, were performed. At the significance level corrected by Bonferroni, 9 immune phenotypes, including CD25 on IgD + CD24- B cell, were associated with ARF; 4 immune phenotypes, including SSC-A on plasmacytoid dendritic cell, were associated with rapid kidney function decline. Sensitivity analysis indicated robust results. Our study demonstrates a strong causal relationship between specific types of immune cells and AKI by genetic means, providing valuable insights for future clinical studies.
- 2 March 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2471011
Open AccessThe association between immune cells and acute kidney injury: insights from Mendelian randomization
Immune disorder is a prominent feature of acute kidney injury (AKI). However, the specific role of different immune cell phenotypes in the pathogenesis of AKI remains poorly understood. The aim of this study was to investigate the relevance of 731 immune phenotypes to AKI. We obtained data on 731 immune cell phenotypes from the GWAS Catalog and Open GWAS databases and undertook a series of quality control measures to identify exposure-related instrumental variables (IV). Data on acute renal failure (ARF) and rapid kidney function decline were obtained from the Finngen R11 and CKDGen databases as an outcome. Subsequently, we performed two-sample Mendelian randomization (MR) using inverse variance weights to explore the causal relationship between 731 immune cell characteristics and ARF and rapid kidney function declineas at the gene level. Sensitivity analyses, including leave-one-out and other MR analysis models, were performed. At the significance level corrected by Bonferroni, 9 immune phenotypes, including CD25 on IgD + CD24- B cell, were associated with ARF; 4 immune phenotypes, including SSC-A on plasmacytoid dendritic cell, were associated with rapid kidney function decline. Sensitivity analysis indicated robust results. Our study demonstrates a strong causal relationship between specific types of immune cells and AKI by genetic means, providing valuable insights for future clinical studies.
- Open Access
- 15 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-14
Structure-based discovery of a new type of scaffold compound as binding competitors for protein-bound Uremic Toxins
Protein-bound uremic toxins (PBUTs) are the main cause of uremia, but traditional hemodialysis is ineffective in removing them because of their strong ability to bind to human serum albumin (HSA), highlighting the need for new treatments. In this study, first, structure-based docking was used to screen a diverse library of 200,376 virtual compounds against the active sites I and II. After two rounds of docking screening, 3944 candidate molecules were obtained. Second, 23 candidate molecules were obtained after ADMET prediction and toxicity analysis. Five candidate molecules were finally obtained after visual analysis and MM-PBSA calculations. We subsequently assessed their competitive displacement efficiency through a microdialysis experiment, and the results revealed that ZINC000008791789, ZINC000012297018, and ZINC000012296493 are promising binding competitors for PBUTs, as they have higher dialysis efficiency than the optimal displacer LA, approximately double the dialysis efficiency. The other two molecules, ZINC000031161007 and ZINC000004090361, although less efficient than LA, still outperformed the control group. Notably, four of them shared the same molecular scaffold, and three of them contained a flavonoid group. These findings provide a foundation for the development of more effective PBUT binding competitors, potentially benefiting uremia patients in the future.
- 15 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-14
Open AccessStructure-based discovery of a new type of scaffold compound as binding competitors for protein-bound Uremic Toxins
Protein-bound uremic toxins (PBUTs) are the main cause of uremia, but traditional hemodialysis is ineffective in removing them because of their strong ability to bind to human serum albumin (HSA), highlighting the need for new treatments. In this study, first, structure-based docking was used to screen a diverse library of 200,376 virtual compounds against the active sites I and II. After two rounds of docking screening, 3944 candidate molecules were obtained. Second, 23 candidate molecules were obtained after ADMET prediction and toxicity analysis. Five candidate molecules were finally obtained after visual analysis and MM-PBSA calculations. We subsequently assessed their competitive displacement efficiency through a microdialysis experiment, and the results revealed that ZINC000008791789, ZINC000012297018, and ZINC000012296493 are promising binding competitors for PBUTs, as they have higher dialysis efficiency than the optimal displacer LA, approximately double the dialysis efficiency. The other two molecules, ZINC000031161007 and ZINC000004090361, although less efficient than LA, still outperformed the control group. Notably, four of them shared the same molecular scaffold, and three of them contained a flavonoid group. These findings provide a foundation for the development of more effective PBUT binding competitors, potentially benefiting uremia patients in the future.
- Open Access
- 23 October 2024
- Published by Springer Nature in The EMBO Journal
- Vol. 43 (23) , 6124-6151
Tight junction protein LSR is a host defense factor against SARS-CoV-2 infection in the small intestine
The identification of host factors with antiviral potential is important for developing effective prevention and therapeutic strategies against SARS-CoV-2 infection. Here, by using immortalized cell lines, intestinal organoids, ex vivo intestinal tissues and humanized ACE2 mouse model as proof-of-principle systems, we have identified lipolysis-stimulated lipoprotein receptor (LSR) as a crucial host defense factor against SARS-CoV-2 infection in the small intestine. Loss of endogenous LSR enhances ACE2-dependent infection by SARS-CoV-2 Spike (S) protein-pseudotyped virus and authentic SARS-CoV-2 virus, and exogenous administration of LSR protects against viral infection. Mechanistically, LSR interacts with ACE2 both in cis and in trans , preventing its binding to S protein, and thus inhibiting viral entry and S protein-mediated cell–cell fusion. Finally, a small LSR-derived peptide blocks S protein binding to the ACE2 receptor in vitro. These results identify both a previously unknown function for LSR in antiviral host defense against SARS-CoV-2, with potential implications for peptide-based pan-variant therapeutic interventions.
- 23 October 2024
- Published by Springer Nature in The EMBO Journal
- Vol. 43 (23) , 6124-6151
Open AccessTight junction protein LSR is a host defense factor against SARS-CoV-2 infection in the small intestine
The identification of host factors with antiviral potential is important for developing effective prevention and therapeutic strategies against SARS-CoV-2 infection. Here, by using immortalized cell lines, intestinal organoids, ex vivo intestinal tissues and humanized ACE2 mouse model as proof-of-principle systems, we have identified lipolysis-stimulated lipoprotein receptor (LSR) as a crucial host defense factor against SARS-CoV-2 infection in the small intestine. Loss of endogenous LSR enhances ACE2-dependent infection by SARS-CoV-2 Spike (S) protein-pseudotyped virus and authentic SARS-CoV-2 virus, and exogenous administration of LSR protects against viral infection. Mechanistically, LSR interacts with ACE2 both in cis and in trans , preventing its binding to S protein, and thus inhibiting viral entry and S protein-mediated cell–cell fusion. Finally, a small LSR-derived peptide blocks S protein binding to the ACE2 receptor in vitro. These results identify both a previously unknown function for LSR in antiviral host defense against SARS-CoV-2, with potential implications for peptide-based pan-variant therapeutic interventions.